secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001558370-23-016426
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics updates corporate presentation slide deck; no specific changes disclosed
--------------------------------------------------------------------------------

- Filed corporate presentation slide deck dated October 2023; title indicates focus on precision oncology and synthetic lethality.
- No quantitative updates (e.g., financial results, clinical data) disclosed in the filing or the provided exhibit excerpt.
- Given the absence of specific changes, materiality of this update appears low.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000155837023016426/0001558370-23-016426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000155837023016426/apre-20231013x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-016426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer